Veterinary cancer solutions, from early detection to ongoing care.
If you can find cancer early, you can find hope.
As a trusted leader in veterinary oncology, IDEXX continues to raise the standard for patient care. And with three recent groundbreaking innovations, we’re just getting started.
How do you return unconditional love? With science.
Our love for pets motivates everything we do. By staying on the cutting edge of oncology, we hope to inspire new treatments, new therapies, new data, and a better future for all pets.
dogs in the U.S. will be diagnosed with cancer in their lifetime.¹
of pet owners globally consider their pet a part of their family.²
Two new tools to detect mast cell tumors are on their way.
IDEXX Cancer Dx testing can soon help detect mast cell tumors early. And when masses are present, the IDEXX inVue Dx Cellular Analyzer can help diagnose mast cell tumors during the patient visit. Whether you're screening a patient or making a diagnosis, time is back on your side.
See all our cancer testsOur vision for cancer begins with seeing it early.
Canine cancer is the leading cause of death in adult dogs. But what if we could change that? Whether you're screening for early cancer or managing treatment, we can help you provide the best possible care.
IDEXX inVue Dx Cellular Analyzer
Diagnose mast cell tumors quickly with FNA capabilities right in your clinic.
Pathology services
Comprehensive support to help you make well- informed, timely decisions for your pathology cases.
Radiology and telemedicine consultants
Dependable answers to your routine and challenging diagnostic questions, when you need them.
Digital cytology
Personalized guidance from veterinary clinical pathologists.
The cancer diagnostics test and service menu gives you the answers you need, when you need them.
Cancer screening
Cancer identification
IDEXX Cancer Dx testing - Priority Cytology
- Priority Biopsy
- Bone Marrow Cytology and Biopsy with Microscopic Description
Cancer characterization
- Mast Cell Tumor Prognostic Panel
- Immunocytochemical Staining, as recommended by pathology
- Immunohistochemistry, as recommended by pathology
- Lymphoma PCR, includes the PARR assay for clonality
Chemotherapy patient monitoring
- Cancer Baseline Profile with Urinalysis
- Cancer Baseline Profile and SediVue Dx Urinalysis†
- Chemotherapy Recheck Profile
- Chemotherapy Recheck Profile with Urinalysis
Other cancer tests
-
Nu.Q Vet Cancer Test - FidoCure DNA Sequencing Panel Add-on to Biopsy
- Hypercalcemia of Malignancy Profile
You support your patients.
We’ll support you.
Get comprehensive support from IDEXX Medical Consulting Services around treatment and prognosis for every oncology case.
*At-risk dogs include all dogs ≥ 7 years old and high-risk breeds ≥ 4 years old.
†Urinalysis is performed on the in-house SediVue Dx Urine Sediment Analyzer.
References
- What are the most common types of cancers in dogs? How many dogs typically get cancer? Veterinary Cancer Society; 2021. Accessed November 6, 2025. www.vetcancersociety.org/pet-owners/faqs
- International survey of pet owners & veterinarians. Human Animal Bond Research Institute. January 16, 2022. Accessed November 6, 2025. www.habri.org/international-hab-survey